BLTE
Belite Bio, Inc. ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website belitebio.com
- Employees(FY) 16
- ISIN US07782B1044
Performance
+5.81%
1W
+25.33%
1M
-5.55%
3M
+20.92%
6M
-1.7%
YTD
+99.88%
1Y
Profile
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases (STGD1). Its lead product candidate is LBS-008 (Tinlarebant), an orally administered, once-a-day tablet for maintaining the health and integrity of retinal tissues in STGD1 and GA patients. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
Investment Analysis Report: BLTE
Overview
BLTE is a pharmaceutical company operating in the Health Technology sector, with a market capitalization of $1.2 billion. In this report, we will conduct a comprehensive analysis of BLTE's financial statements over the past three years to evaluate its valuation, financial health, earnings and revenue gro...
Technical Analysis of BLTE 2024-05-10
Overview:
In analyzing the technical indicators for BLTE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysi...
Recent News & Updates
- 2024-05-14 08:00
- 2024-05-14 05:17
Belite Bio's Q1 Loss Narrows(MT Newswires)
- 2024-05-13 21:50
- 2024-05-13 20:00
- 2024-05-13 19:53
BLTE Stock Earnings: Belite Bio Misses EPS for Q1 2024(Investorplace)
- 2024-05-13 09:50
- 2024-05-13 08:00
- 2024-05-12 20:00
- 2024-05-08 08:00
- 2024-05-07 20:00
- 2024-05-06 08:15
- 2024-05-06 08:00
- 2024-05-05 20:15
- 2024-05-05 20:00
- 2024-05-01 16:15
- 2024-05-01 04:15
- 2024-04-26 06:21
- 2024-04-25 19:15
Belite Bio Announces $25 Million Registered Direct Offering(GlobeNewswire)
- 2024-04-25 07:15
Belite Bio Announces $25 Million Registered Direct Offering(Globenewswire)
- 2024-04-10 09:55
- 2024-04-09 21:55
- 2024-03-22 08:00
- 2024-03-21 20:00
- 2024-03-20 07:32
- 2024-03-11 22:28
- 2024-03-11 21:27
- 2024-03-11 10:28
- 2024-03-11 09:27
- 2024-03-06 08:00
- 2024-03-05 19:00
Page 1 of 3
previousnext